Biologics for chronic rhinosinusitis with nasal polyps.

Key Findings

• ●Comprehensive review of biologic mechanisms
• ●Comparison of dupilumab, omalizumab, mepolizumab efficacy
• ●Endotype-based treatment selection

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

   Identifier corrected: prior entry (doi-10-1016-j-jaci-2020-07-032) had a wrong PMID/DOI pointing to an unrelated paper; re-resolved by title to this record via PubMed/Crossref.

   tools: pubmed.esummary, crossref.works